Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease

International Journal of COPD

Volumn 8, Issue , 2013, Pages 273-286

  Kocks, Jan Willem H ^a   van den Berg, Jan Willem K ^b   Kerstjens, Huib A M ^a   Uil, Steven M ^b   Vonk, Judith M ^a   de Jong, Ynze P ^b   Tsiligianni, Ioanna G ^a   van der Molen, Thys ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Pulmonary Diseases ^*  (Netherlands)

Author keywords

Admission; Clinical COPD questionnaire; Health status; Hospital; Prediction

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; PLACEBO; PREDNISOLONE;

AGE; ARTICLE; BORG DYSPNEA SCALE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL COPD QUESTIONNAIRE; CONVALESCENCE; DISEASE EXACERBATION; DRUG MEGADOSE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HOSPITAL PATIENT; HUMAN; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; SEX DIFFERENCE; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TREATMENT FAILURE;

ADMISSION; CLINICAL COPD QUESTIONNAIRE; HEALTH STATUS; HOSPITAL; PREDICTION;

ADRENAL CORTEX HORMONES; AGED; DISEASE PROGRESSION; DYSPNEA; FEMALE; HEALTH STATUS DISPARITIES; HOSPITALIZATION; HUMANS; MALE; MAXIMAL EXPIRATORY FLOW RATE; MIDDLE AGED; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PARTICIPATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF REPORT; SURVIVAL ANALYSIS;

EID: 84878983593     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S43992     Document Type: Article

References (49)

1. Seemungal TA, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD - a review of potential interventions. Int J Chron Obstruct Pulmon Dis. 2009;4:203-223.
2. Almagro P, Calbo E, Ochoa de Echagüen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121:1441-1448.
3. Soler-Cataluna JJ, Martinez-Garcia MA, Roman SP, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925-931.
4. Wouters EF. The burden of COPD in The Netherlands: Results from the Confronting COPD survey. Respir Med. 2003;97 Suppl C:S51-S59.
5. Bourbeau J, Ford G, Zackon H, et al. Impact on patients' health status following early identification of a COPD exacerbation. Eur Respir J. 2007;30:907-913.
6. Doll H, Grey-Amante P, Duprat-Lomon I, et al. Quality of life in acute exacerbation of chronic bronchitis: results from a German population study. Respir Med. 2002;96:39-51.
7. Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009;4:245-251.
8. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23:698-702.
9. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847-852.
10. [No authors listed]. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. Available from: http://www.goldcopd.org/. Accessed March 30. 2013.
11. Wildman MJ, O'Dea J, Kostopoulou O, et al. Variation in intubation decisions for patients with chronic obstructive pulmonary disease in one critical care network. QJM. 2003;96:583-591.
12. Escher M, Perneger TV, Chevrolet JC. National questionnaire survey on what influences doctors' decisions about admission to intensive care. BMJ. 2004;329:425.
13. Roche N, Rabbat A, Zureik M, Huchon G. Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome. Curr Opin Pulm Med. 2010;16:112-117.
14. Wildman MJ, Sanderson C, Groves J, et al. Predicting mortality for patients with exacerbations of COPD and asthma in the COPD and asthma outcome study (CAOS). QJM. 2009;102:389-399.
15. Roche N, Zureik M, Soussan D, et al. Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J. 2008;32:953-961.
16. Doll H, Miravitlles M. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature. Pharmacoeconomics. 2005;23:345-363.
17. Postma D, Anzueto A, Calverley P, et al. A new perspective on optimal care for patients with COPD. Prim Care Respir J. 2011;20:205-209.
18. van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1:13.
19. Cave AJ, Atkinson L, Tsiligianni I, Kaplan A. Assessment of COPD wellness tools for use in primary care: an IPCRG initiative. Int J COPD. 2012;7:447-456.
20. De Jong YP, Uil SM, Grotjohan HP, et al. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. Chest. 2007;132:1741-1747.
21. Bathoorn E, Liesker JJ, Postma DS, et al. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. COPD. 2008;5:282-290.
22. Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005;2:111-124.
23. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377-381.
24. Grant S, Aitchison T, Henderson E, et al. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest. 1999;116:1208-1217.
25. Ries AL. Minimally clinically important difference for the UCSD shortness of breath questionnaire, Borg scale, and visual analog scale. COPD. 2005;2:105-110.
26. Kocks JW, Tuinenga MG, Uil SM, et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7:62.
27. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med. 1991;85 Suppl B:25-31.
28. Jones PW. Interpretation of health status measurements: from clinical trials to routine practice. Eur Respir Rev. 2002;12:87.
29. Kocks JWH, Kerstjens HAM, van den Berg JWK, van der Molen T. The course of health status during an exacerbation of COPD in hospitalized patients versus out-patient treated patients. Prim Care Respir J. 2010; 19:A8-A9.
30. Ferrari R, Tanni SE, Caram LM, et al. Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2011;9:112.
31. Nishimura K, Sato S, Tsukino M, et al. Effect of exacerbations on health status in subjects with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2009;7:69.
32. Stevenson NJ, Walker PP, Costello RW, Calverley PM. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:1510-1516.
33. Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2002;165: 698-703.
34. Trappenburg JC, Monninkhof EM, Bourbeau J, et al. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax. 2011;66:977-984.
35. Leidy NK, Wilcox TK, Jones PW, et al. Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med. 2011;183:323-329.
36. Celli BR, Vestbo J. The EXACT-PRO: measuring exacerbations of COPD. Am J Respir Crit Care Med. 2011;183:287-288.
37. Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract. 2007;24:217-223.
38. Ng TP, Niti M, Tan WC, et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167:60-67.
39. Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608-1613.
40. Aaron SD, Donaldson GC, Whitmore GA, et al. Time course and pattern of COPD exacerbation onset. Thorax. 2012;67:238-243.
41. van den Berge M, Hop WC, van der Molen T, et al; COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group. Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease. Respir Res. 2012;13:44.
42. Koutsokera A, Kiropoulos TS, Nikoulis DJ, et al. Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respir Med. 2009;103:919-926.
43. Pinto-Plata VM, Livnat G, Girish M, et al. Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest. 2007;131:37-43.
44. Nevins ML, Epstein SK. Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest. 2001;119: 1840-1849.
45. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalized patients with COPD. Eur Respir J. 2005;26:234-241.
46. Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67:957-963.
47. Nishimura K. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434-1440.
48. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363: 1128-1138.
49. Mackay AJ, Donaldson GC, Patel AR, et al. Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med. 2012;185: 1218-1224.